Ticagrelor Tablets
Acute Coronary Syndrome
Key Facts
About Indoco Remedies
Founded in 1947, Indoco Remedies has evolved from a trading concern into a $15+ billion market cap pharmaceutical enterprise with a mission to deliver high-quality, affordable medicines globally. Its core strategy is built on vertical integration, combining API synthesis with sophisticated formulation development in complex generics, particularly sterile injectables, ophthalmics, and oral solutions. Recent achievements include multiple USFDA ANDA approvals, successful regulatory inspections with zero observations, and strategic expansion into key international markets like the US and Europe through partnerships and acquisitions.
View full company profileOther Acute Coronary Syndrome Drugs
| Drug | Company | Phase |
|---|---|---|
| Cardiac Troponin SMAs | Bioventix | Commercial |